Guj. Themis Bio.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
227.45
-24.1 (-9.58%)
BSENSE

Mar 30

BSE+NSE Vol: 2.08 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGuj. Themis Bio. VS Pharmaceuticals & Biotechnology
 
1D
-9.58%
-2.22%
1W
-12.11%
-1.03%
1M
-23.02%
-10.33%
YTD
-48.59%
-15.57%
1Y
-19.2%
-7.06%
3Y
149.35%
24.13%
5Y
747.15%
43.5%
10Y
3329.07%
183.94%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.27%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-47.73%
0%
-47.73%
6 Months
-42.72%
0%
-42.72%
1 Year
-19.2%
0.27%
-18.93%
2 Years
-13.0%
0.36%
-12.64%
3 Years
149.35%
2.80%
152.15%
4 Years
304.01%
20.43%
324.44%
5 Years
747.15%
51.62%
798.77%

Latest dividend: 0.67 per share ex-dividend date: Sep-04-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available